|
LRRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25579999999503E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.003000E-04 |
| Normal-vs-Stage2 |
1.216750E-03 |
| Normal-vs-Stage3 |
2.571300E-04 |
| Normal-vs-Stage4 |
2.41239999998477E-06 |
| Stage1-vs-Stage2 |
5.967400E-01 |
| Stage1-vs-Stage3 |
7.107400E-01 |
| Stage1-vs-Stage4 |
3.866300E-02 |
| Stage2-vs-Stage3 |
8.036400E-01 |
| Stage2-vs-Stage4 |
3.422600E-01 |
| Stage3-vs-Stage4 |
1.352240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.3294000000067E-05 |
| Normal-vs-AfricanAmerican |
4.020300E-02 |
| Normal-vs-Asian |
8.424000E-04 |
| Caucasian-vs-AfricanAmerican |
6.806200E-01 |
| Caucasian-vs-Asian |
5.337800E-01 |
| AfricanAmerican-vs-Asian |
4.542600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.28109999999404E-05 |
| Normal-vs-Female |
6.3181999999995E-05 |
| Male-vs-Female |
6.835400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.211290E-04 |
| Normal-vs-Age(41-60Yrs) |
3.157100E-03 |
| Normal-vs-Age(61-80Yrs) |
7.92310000052865E-07 |
| Normal-vs-Age(81-100Yrs) |
1.737530E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.240800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.385550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.282400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.761800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.585200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.869000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.600200E-01 |
| Classical-VS-Follicular |
1.015770E-02 |
| Classical-VS-Other |
3.694600E-01 |
| Classical-VS-Normal |
5.160600E-04 |
| Tall-VS-Follicular |
1.935390E-01 |
| Tall-VS-Other |
2.973400E-01 |
| Tall-VS-Normal |
5.571500E-04 |
| Follicular-VS-Other |
1.950600E-01 |
| Follicular-VS-Normal |
1.14610000001569E-06 |
| Other-VS-Normal |
9.002400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.10469999999808E-05 |
| Normal-vs-N1 |
3.65920000000575E-05 |
| N0-vs-N1 |
1.994430E-01 |
|
|
